EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

LOGO

 

Contact:
Abdo H. Khoury
Chief Financial and Portfolio Officer
(949) 718-4400

NHP REPORTS THIRD QUARTER 2008 EARNINGS

Revenue Increases 18.9%

Recurring Diluted FFO Per Share Increases 5.7%

Recurring Diluted FAD Per Share Increases 1.9%

Third Quarter Investments Total $125 Million

NEWPORT BEACH, CA – November 4, 2008 – Nationwide Health Properties, Inc. (NYSE: NHP) today announced results of operations and investment activity for the third quarter and the nine months ended September 30, 2008.

“Our third quarter results continue the positive trends from the first half of 2008. Compared to the third quarter of 2007, revenue is up 18.9%, recurring diluted FFO per share is up 5.7%, and recurring diluted FAD per share is up 1.9%. Our year to date results reflect revenue up 23.0%, recurring diluted FFO per share up 9.1%, and recurring diluted FAD per share up 5.1%,” commented Douglas M. Pasquale, NHP’s President and Chief Executive Officer. “We continue our disciplined approach to acquisitions and balance sheet management. Our conservative leverage, comfortable fixed charge coverage, excellent liquidity and modest debt maturities through June 2011 position us very well in this challenging and uncertain capital market environment. Our diluted FAD payout ratio and FAD coverage remain among the strongest in our sector at 80% and 1.25, respectively,” Mr. Pasquale added.

THIRD QUARTER 2008 RESULTS OF OPERATIONS

The following table presents selected financial information for the third quarter and the nine months ended September 30, 2008 as compared to the same periods of 2007:

 

1


SELECTED FINANCIAL DATA

($ in thousands, except per share amounts)

 

     Three Months Ended September 30,  
     2008    2007    $ Change     % Change  

Revenue

   $ 95,475    $ 80,308    $ 15,167     18.9 %

Income from Continuing Operations

   $ 26,873    $ 54,162    $ (27,289 )   -50.4 %

Net Income

   $ 29,253    $ 57,742    $ (28,489 )   -49.3 %

Income Available to Common Stockholders

          

Per Diluted Share

   $ 0.27    $ 0.58    $ (0.31 )   -53.4 %

Diluted FFO

   $ 58,413    $ 52,926    $ 5,487     10.4 %

Recurring Diluted FFO

   $ 58,413    $ 50,961    $ 7,452     14.6 %

Diluted FFO Per Share

   $ 0.56    $ 0.55    $ 0.01     1.8 %

Recurring Diluted FFO Per Share

   $ 0.56    $ 0.53    $ 0.03     5.7 %

Diluted FAD

   $ 57,109    $ 54,003    $ 3,106     5.8 %

Recurring Diluted FAD

   $ 57,109    $ 52,038    $ 5,071     9.7 %

Diluted FAD Per Share

   $ 0.55    $ 0.56    $ (0.01 )   -1.8 %

Recurring Diluted FAD Per Share

   $ 0.55    $ 0.54    $ 0.01     1.9 %
     Nine Months Ended September 30,  
     2008    2007    $ Change     % Change  

Revenue

   $ 275,691    $ 224,069    $ 51,622     23.0 %

Income from Continuing Operations

   $ 77,972    $ 95,340    $ (17,368 )   -18.2 %

Net Income

   $ 234,722    $ 171,222    $ 63,500     37.1 %

Income Available to Common Stockholders

          

Per Diluted Share

   $ 2.34    $ 1.77    $ 0.57     32.2 %

Diluted FFO

   $ 172,511    $ 148,212    $ 24,299     16.4 %

Recurring Diluted FFO

   $ 172,511    $ 146,247    $ 26,264     18.0 %

Diluted FFO Per Share

   $ 1.68    $ 1.56    $ 0.12     7.7 %

Recurring Diluted FFO Per Share

   $ 1.68    $ 1.54    $ 0.14     9.1 %

Diluted FAD

   $ 167,769    $ 150,330    $ 17,439     11.6 %

Recurring Diluted FAD

   $ 167,769    $ 148,365    $ 19,404     13.1 %

Diluted FAD Per Share

   $ 1.64    $ 1.58    $ 0.06     3.8 %

Recurring Diluted FAD Per Share

   $ 1.64    $ 1.56    $ 0.08     5.1 %

Income from Continuing Operations

In 2007, we sold properties to our unconsolidated joint venture. Under generally accepted accounting principles (“GAAP”), we were required to recognize a gain on this sale and because we have a continuing involvement in these properties through an unconsolidated joint venture, we were required to include this gain on sale in income from continuing operations. As a result, our income from continuing operations for the three and nine months ending September 30, 2007, is substantially greater than the three and nine months ending September 30, 2008.

 

2


THIRD QUARTER 2008 INVESTMENT ACTIVITY

The following table summarizes our 2008 investment activity:

INVESTMENT ACTIVITY 2008

($ in thousands)

 

Investment

   Q1
Total
    Q2
Total
    Q3
Owned
    Q3
Loans
    Q3
Total
    Year to Date
Total
 

Senior Housing

 

Number of Facilities

     14       1           —         15  

Purchase Price

   $ 52,000     $ 20,000         $ —       $ 72,000  

Initial Yield

     8.1 %     8.4 %           8.2 %

Long-Term Care

            

Number of Facilities

       7       5         5       12  

Purchase Price

     $ 32,000     $ 31,200       $ 31,200     $ 63,200  

Initial Yield

       9.8 %     9.6 %       9.6 %     9.7 %

Medical Office

            

Number of Facilities

     1       8       14       1       15       24  

Purchase Price

   $ 2,000     $ 198,000     $ 46,400     $ 47,500     $ 93,900     $ 293,900  

Initial Yield

     7.4 %     6.2 %     7.7 %     6.5 %     7.1 %     6.5 %

Total

            

Number of Facilities

     15       16       19       1       20       51  

Purchase Price

   $ 54,000     $ 250,000     $ 77,600     $ 47,500     $ 125,100     $ 429,100  

Initial Yield

     8.1 %     6.8 %     8.5 %     6.5 %     7.7 %     7.2 %

Pacific Medical Buildings LLC (“PMB”) Update – In February 2008, we entered into an agreement with PMB and certain of its affiliates to acquire up to 18 multi-tenant medical office buildings, six of which are currently in development, for $747.6 million including the assumption of approximately $282.6 million of mortgage financing. During the nine months ended September 30, 2008, we acquired 8 of such buildings for a total of $197.2 million, including the assumption of $96.6 million of mortgage financing and the issuance of 1,470,754 limited partnership units with a value of $47.3 million. Additionally in September 2008, we made a mortgage loan to an entity affiliated with PMB for $47.5 million due December 31, 2008. The loan is secured by a property that we intend to purchase in the fourth quarter 2008.

2008 FINANCING TRANSACTIONS

During the third quarter of 2008, we issued 1,329,000 shares of our common stock through our controlled equity offering program at an average price of $35.32 per share resulting in net proceeds of approximately $46.4 million. For the nine months ended September 30, 2008, we have issued 2.6 million shares of our common stock through our controlled equity offering program at an average price of $34.97 per share resulting in net proceeds of approximately $89.1 million.

 

3


STOCK REPURCHASE PROGRAM

NHP also announced today that its Board of Directors has approved the expenditure of up to $100 million to repurchase shares of the company’s common stock. The stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as current stock price, cash requirements for acquisitions, repayment of debt, and other factors. NHP may repurchase shares from time to time on the open market or in privately negotiated transactions as permitted by securities laws and other legal requirements. The stock repurchase program does not require the purchase of any minimum number of shares and may be suspended, modified or discontinued at any time without prior notice. “The Board’s approval of the share repurchase program reflects its confidence in the continued growth of NHP’s business and an ongoing commitment to increase shareholder value,” said Abdo Khoury, Chief Financial and Portfolio Officer. “We have maintained a strong balance sheet and feel confident that this program adds flexibility to our strategic options surrounding the deployment of our capital.”

2008 GUIDANCE

We are increasing by $0.02 per share the low end of our full-year 2008 diluted FFO guidance from $2.19 per share to $2.21 per share and are increasing by $0.01 the high end of the range from $2.23 per share to $2.24 per share. We are also increasing by $0.02 per share the low end of our full-year 2008 diluted FAD guidance from $2.11 per share to $2.13 per share and are increasing by $0.01 the high end of the range from $2.15 per share to $2.16 per share. Annualizing our year to date diluted FAD per share would result in an amount greater than the high end of our range, however, such analysis does not reflect the timing of capital expenditures and tenant improvements for medical office buildings (“MOBs”). Certain factors could effect our diluted FFO per share and diluted FAD per share such as the slower than expected reinvestment of proceeds from the sale of the Emeritus assets and the issuance of 1,329,000 shares of common stock during the third quarter. Our guidance includes the additional acquisitions of MOBs from PMB as well as expected mortgage loan receivable prepayments and dispositions during 2008 as described in our supplemental information package available on our website. However, while we expect to continue to make accretive acquisitions during 2008, our diluted FFO per share and diluted FAD per share guidance ranges do not assume any additional acquisitions or investments, impairments or capital transactions.

CONFERENCE CALL INFORMATION

We have scheduled a conference call and webcast on Wednesday, November 5, 2008 at 8:30 a.m. Pacific time in order to present our performance and operating results for the quarter and nine months ended September 30, 2008. The conference call is accessible by dialing 877-356-5705 and referencing conference ID number 68594782 or by logging on to our website at http://www.nhp-reit.com. The international dial-in number is 973-200-3389. The earnings release and any additional financial information that may be discussed on the conference call will also be available at the same location on our

 

4


website. A digitized replay of the conference call will be available from 10:30 a.m. Pacific time (1:30 p.m. Eastern time) that day until 9:00 p.m. Pacific time (Midnight Eastern time) on Friday, December 5, 2008. Callers can access the replay by dialing 800-642-1687 or 706-645-9291 and entering conference ID number 68594782. Webcast replays will also be available on our website for at least 12 months following the conference call. Our supplemental information package for the quarter ended September 30, 2008 is available on our website, free of charge, at http://www.nhp-reit.com by selecting “Investor Relations” followed by “Financial Information” and will be included in our Current Report on Form 8-K filed November 4, 2008 with the SEC also containing this release.

ABOUT NATIONWIDE HEALTH PROPERTIES, INC.

Nationwide Health Properties, Inc. is a real estate investment trust that invests in senior housing facilities, long-term care facilities and medical office buildings. We have investments in 580 facilities in 43 states. For more information on Nationwide Health Properties, Inc., visit our website at http://www.nhp-reit.com.

FORWARD LOOKING STATEMENTS

Certain information contained in this release includes forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are not statements of historical facts. These statements may be identified, without limitation, by the use of forward-looking terminology such as “may,” “will,” “anticipates,” “expects,” “believes,” “intends,” “should” or comparable terms or the negative thereof. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements. Risks and uncertainties associated with our business include (without limitation) the following: deterioration in the operating results or financial condition, including bankruptcies, of our tenants; non-payment or late payment of rent by our tenants; our reliance on two tenants for a significant percentage of our revenue; occupancy levels at certain facilities; our level of indebtedness; changes in the ratings of our debt securities; access to the capital markets and the cost of capital; government regulations, including changes in the reimbursement levels under the Medicare and Medicaid programs; the general distress of the healthcare industry; increasing competition in our business sector; the effect of economic and market conditions and changes in interest rates; the amount and yield of any additional investments; risks associated with acquisitions, including our ability to identify and complete favorable transactions, delays or failures in obtaining third party consents or approvals, the failure to achieve perceived benefits, unexpected costs or liabilities and potential litigation; the ability of our tenants to repay straight-line rent or loans in future periods; the ability of our tenants to obtain and maintain adequate liability and other insurance; our ability to attract new tenants for certain facilities; our ability to sell certain facilities for their book value; our ability to retain key personnel; potential liability under environmental laws; the possibility that we could be required to repurchase some of our

 

5


senior notes; the rights and influence of holders of our outstanding preferred stock; changes in or inadvertent violations of tax laws and regulations and other factors that can affect real estate investment trusts and our status as a real estate investment trust; and other factors discussed from time to time in our news releases, public statements and/or filings with the Securities and Exchange Commission, especially the “Risk Factors” sections of our Annual and Quarterly Reports on Forms 10-K and 10-Q. Forward-looking information is provided by us pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. We disclaim any intent or obligation to update these forward-looking statements.

NON-GAAP FINANCIAL MEASURES

Diluted Funds From Operations (“FFO”) and Diluted Funds Available for Distribution (“FAD”) are non-GAAP measures that we believe are important to understanding our operations. We believe diluted FFO is an important supplemental measure of operating performance because it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). We believe diluted FAD is an important supplemental measure of operating performance because, like diluted FFO, it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). It also excludes straight-lined rent and other non-cash items that have become more significant for us and our competitors over the last several years. We believe that net income is the most directly comparable GAAP measure to diluted FFO and diluted FAD. Reconciliations between net income and diluted FFO and net income and diluted FAD are included in the accompanying financial data. For guidance, we have also included in the accompanying financial data reconciliations between net income per share and diluted FFO and diluted FAD per share. We have also included recurring diluted FFO and recurring diluted FAD amounts which exclude the recognition of revenue related to cash received from a tenant related to previously reserved rental revenue, interest income and late charges.

***Financial Tables to Follow***

 

6


NATIONWIDE HEALTH PROPERTIES, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

 

     Three Months Ended September 30,     Nine Months Ended September 30,  
     2008     2007     2008     2007  

Revenue:

        

Triple net lease rent

   $ 72,673     $ 70,188     $ 214,203     $ 199,111  

Medical office building operating rent

     16,188       3,560       43,058       9,133  
                                
     88,861       73,748       257,261       208,244  

Interest and other income

     6,614       6,560       18,430       15,825  
                                
     95,475       80,308       275,691       224,069  

Expenses:

        

Interest and amortization of deferred financing costs

     25,308       24,297       75,554       72,205  

Depreciation and amortization

     30,416       23,851       86,776       65,277  

General and administrative

     6,634       6,080       19,538       17,493  

Medical office building operating expenses

     7,220       1,891       18,782       5,084  
                                
     69,578       56,119       200,650       160,059  
                                

Income before minority interests, unconsolidated joint ventures and discontinued operations

     25,897       24,189       75,041       64,010  

Minority interests

     52       76       107       139  

Income from unconsolidated joint ventures

     924       547       2,824       1,242  

Gain on sale of facilities to unconsolidated joint venture

     —         29,350       —         29,949  
                                

Income from continuing operations

     26,873       54,162       77,972       95,340  

Discontinued operations

        

Gain on sale of facilities, net

     2,351       39       153,444       61,285  

Income from discontinued operations

     29       3,541       3,306       14,597  
                                
     2,380       3,580       156,750       75,882  
                                

Net income

     29,253       57,742       234,722       171,222  

Preferred stock dividends

     (2,061 )     (3,791 )     (6,185 )     (11,372 )
                                

Income available to common stockholders

   $ 27,192     $ 53,951     $ 228,537     $ 159,850  
                                

Basic earnings per share (EPS):

        

Income from continuing operations excluding gains

   $ 0.26     $ 0.23     $ 0.75     $ 0.61  

Gains in income from continuing operations

     —         0.32       —         0.33  
                                

Income from continuing operations

     0.26       0.55       0.75       0.94  

Discontinued operations

     0.02       0.04       1.63       0.84  
                                

Income available to common stockholders

   $ 0.28     $ 0.59     $ 2.38     $ 1.78  
                                

Diluted EPS:

        

Income from continuing operations excluding gains

   $ 0.25     $ 0.24     $ 0.74     $ 0.60  

Gain in income from continuing operations

     —         0.30       —         0.33  
                                

Income from continuing operations

     0.25       0.54       0.74       0.93  

Discontinued operations

     0.02       0.04       1.60       0.84  
                                

Income available to common stockholders

   $ 0.27     $ 0.58     $ 2.34     $ 1.77  
                                

Weighted average shares outstanding for EPS:

        

Basic

     96,975       91,089       96,203       89,690  
                                

Diluted

     99,032       96,255       97,648       90,158  
                                

 

7


NATIONWIDE HEALTH PROPERTIES, INC.

RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES

(In thousands, except per share data)

 

Reconciliation of Net Income to Diluted FFO and Recurring Diluted FFO  
     Three Months Ended September 30,     Nine Months Ended September 30,  
     2008     2007     2008     2007  

Net income

   $ 29,253     $ 57,742     $ 234,722     $ 171,222  

Preferred stock dividends

     (2,061 )     (3,791 )     (6,185 )     (11,372 )

Real estate related depreciation and amortization

     30,290       25,799       87,766       72,375  

Depreciation in income from unconsolidated joint ventures

     1,221       503       3,467       1,034  

Gains on sale of facilities

     (2,351 )     (29,389 )     (153,444 )     (91,234 )
                                

FFO available to common stockholders

     56,352       50,864       166,326       142,025  

Series B preferred dividends

     2,061       2,062       6,185       6,187  
                                

Diluted FFO

     58,413       52,926       172,511       148,212  

Non-recurring settlement of delinquent tenant obligations

     —         (1,965 )     —         (1,965 )
                                

Recurring diluted FFO

   $ 58,413     $ 50,961     $ 172,511     $ 146,247  
                                

Weighted average shares outstanding for diluted FFO:

        

Diluted weighted average shares outstanding

     99,032       91,544       97,648       90,158  

Series B preferred stock conversion

     4,744       4,711       4,736       4,704  
                                

Fully diluted weighted average shares outstanding

     103,776       96,255       102,384       94,862  
                                

Diluted FFO per share

   $ 0.56     $ 0.55     $ 1.68     $ 1.56  
                                

Recurring diluted FFO per share

   $ 0.56     $ 0.53     $ 1.68     $ 1.54  
                                

Dividends declared per common share

   $ 0.44     $ 0.41     $ 1.32     $ 1.23  
                                

Recurring diluted FFO payout ratio

     79 %     77 %     79 %     80 %
                                

Recurring diluted FFO coverage

     1.27       1.29       1.27       1.25  
                                

 

8


NATIONWIDE HEALTH PROPERTIES, INC.

RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES

(In thousands, except per share data)

 

Reconciliation of Net Income to Diluted FAD and Recurring Diluted FAD  
     Three Months Ended September 30,     Nine Months Ended September 30,  
     2008     2007     2008     2007  

Net income

   $ 29,253     $ 57,742     $ 234,722     $ 171,222  

Preferred stock dividends

     (2,061 )     (3,791 )     (6,185 )     (11,372 )

Real estate related depreciation and amortization

     30,290       25,799       87,766       72,375  

Gains on sale of facilities

     (2,351 )     (29,389 )     (153,444 )     (91,234 )

Straight-lined rent

     (2,280 )     (226 )     (7,877 )     (1,924 )

Amortization of above and below market lease intangibles

     (137 )     (69 )     (411 )     (22 )

Non-cash stock-based compensation expense

     1,500       1,248       4,271       3,486  

Deferred finance cost amortization

     741       683       2,265       2,066  

Lease commissions and tenant and capital improvements

     (1,105 )     (565 )     (2,999 )     (1,498 )

Unconsolidated joint ventures:

        

Real estate related depreciation and amortization

     1,221       503       3,467       1,034  

Straight-lined rent

     (44 )     —         (54 )     —    

Deferred finance cost amortization

     21       6       63       10  
                                

FAD available to common stockholders

     55,048       51,941       161,584       144,143  

Series B preferred dividends

     2,061       2,062       6,185       6,187  
                                

Diluted FAD

     57,109       54,003       167,769       150,330  

Non-recurring settlement of delinquent tenant obligations

     —         (1,965 )     —         (1,965 )
                                

Recurring diluted FAD

   $ 57,109     $ 52,038     $ 167,769     $ 148,365  
                                

Weighted average shares outstanding for diluted FAD:

        

Weighted average shares outstanding

     99,032       91,544       97,648       90,158  

Series B preferred stock conversion

     4,744       4,711       4,736       4,704  
                                

Fully diluted weighted average shares outstanding

     103,776       96,255       102,384       94,862  
                                

Diluted FAD per share

   $ 0.55     $ 0.56     $ 1.64     $ 1.58  
                                

Recurring FAD diluted per share

   $ 0.55     $ 0.54     $ 1.64     $ 1.56  
                                

Dividends declared per common share

   $ 0.44     $ 0.41     $ 1.32     $ 1.23  
                                

Recurring diluted FAD payout ratio

     80 %     76 %     80 %     79 %
                                

Recurring diluted FAD coverage

     1.25       1.32       1.24       1.27  
                                

 

Reconciliation of 2008 Net Income Guidance to 2008 Diluted FFO and Diluted FAD Guidance on a Per Share Basis  
     Low     High  

Net income

   $ 2.55     $ 2.58  

Real estate related depreciation and amortization

     1.24       1.24  

Less: gains on sale

     (1.56 )     (1.56 )

Dilution from convertible preferred stock

     (0.02 )     (0.02 )
                

Diluted FFO guidance

     2.21       2.24  
                

Straight-lined rent

     (0.11 )     (0.11 )

Non-cash stock-based compensation expense

     0.05       0.05  

Deferred finance cost amortization

     0.03       0.03  

Lease commissions and tenant and capital improvements

     (0.05 )     (0.05 )
                

Diluted FAD guidance

   $ 2.13     $ 2.16  
                

 

9


NATIONWIDE HEALTH PROPERTIES, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands)

 

     September 30,
2008
    December 31,
2007
 

Assets

    

Real estate related investments:

    

Land

   $ 313,530     $ 301,100  

Buildings and improvements

     3,001,616       2,896,876  
                
     3,315,146       3,197,976  

Less accumulated depreciation

     (463,156 )     (410,865 )
                

Net real estate

     2,851,990       2,787,111  

Mortgage loans receivable, net

     116,005       121,694  

Mortgage loan receivable from related party

     47,500       —    

Investment in unconsolidated joint ventures

     54,445       52,637  
                

Net real estate related investments

     3,069,940       2,961,442  

Cash and cash equivalents

     114,385       19,407  

Receivables, net

     5,203       3,808  

Other assets

     244,848       159,696  
                

Total assets

   $ 3,434,376     $ 3,144,353  
                

Liabilities and Stockholders’ Equity

    

Unsecured senior credit facility

   $ —       $ 41,000  

Senior notes due 2008 - 2038

     1,139,473       1,166,500  

Notes and bonds payable

     412,812       340,150  

Accounts payable and accrued liabilities

     134,141       107,844  
                

Total liabilities

     1,686,426       1,655,494  

Minority interest

     50,555       6,166  

Stockholders’ equity:

    

Series B convertible preferred stock

     106,390       106,445  

Common stock

     9,825       9,481  

Capital in excess of par value

     1,678,965       1,565,249  

Cumulative net income

     1,523,473       1,288,751  

Accumulated other comprehensive income

     2,197       2,561  

Cumulative dividends

     (1,623,455 )     (1,489,794 )
                

Total stockholders’ equity

     1,697,395       1,482,693  
                

Total liabilities and stockholders’ equity

   $ 3,434,376     $ 3,144,353  
                

 

10